Treadmill test shows how Ampligen may help

by Sasha Nimmo Drug company research team identifies which CFS patients may respond best to Ampligen. Hemispherx Biopharma has identified new criteria to see which CFS patients may get significant clinical benefit from Ampligen (rintatolimod). Patients who are able to complete more than 9 minutes of exercise (modified Bruce protocol exercise tolerance test) are likely to benefit from Ampligen. Data from a previous Phase … Continue reading Treadmill test shows how Ampligen may help